EMA Updates Reexamination Process for Pediatric Trial Plans

Clinical Trials Advisor
A A
Drugmakers should notify the European Medicines Agency within 10 days of receiving an initial opinion on a pediatric investigation plan if they plan to request another review.

To View This Article:

Login

Subscribe To Clinical Trials Advisor